Biologics
2 articles
Markets
Biologics CDMO Market Poised for 9.4% CAGR Amidst Outsourcing Boom
The U.S. Department of Health and Human Services granted over USD 1.00 billion to four BARDA Clinical Trial partners in August 2023 to support vaccine Phase IIb clinical trials, according to Fortune B
Olivia Hartwell·June 18, 2026
Markets
Global Retinal Drugs Biologics Market Forecast to 2035 Shows Growth
The global retinal drugs and biologics market is projected for significant growth through 2035, primarily driven by aging populations and the increasing prevalence of diabetes. This expansion is also fueled by ongoing therapeutic innovation, including next-generation treatments for conditions like nAMD, DME, and geographic atrophy.
Olivia Hartwell·April 5, 2026